Opinion

Video

Addressing Challenges in BCG-Unresponsive NMIBC: Overview and Unmet Needs

Author(s):

Max Kates, MD, discusses how BCG-unresponsive non-muscle invasive bladder cancer patients historically faced limited treatment options beyond radical cystectomy, with significant unmet needs in preserving bladder function while effectively treating this aggressive disease.

  1. Would you please start by giving a brief overview of BCG-unresponsive NMIBC? Nonmuscle Invasive Bladder Cancer
  2. Prior to recent therapeutic innovations in the bladder space what challenges or unmet needs did you face when treating these patients?
Related Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.